The antibody discovery services and platforms market is projected to grow at an annualized rate of ~

Roots Analysis has done a detailed study on Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

Key Market Insights

Over 80 companies are offering antibody discovery services; of these, more than 75 players claim to offer services related to hit generation.
Nearly 180 innovative technology platforms have been developed by numerous firms for the purpose of antibody discovery.
Majority of stakeholders in the competitive market landscape are small / mid-sized firms, catering to the needs of a diverse clientele.
In order to get an edge over their competitors in the industry, companies have established their presence in different regions across the globe.
The rising interest in this field is reflected in the number of partnerships inked in the recent past, involving both international and indigenous stakeholders, and focused on antibody discovery for diverse range of indications.
Efforts of the players in the field of antibody discovery have garnered significant interest of several venture capital investors.
The antibody discovery services market is expected to witness growth at a CAGR of ~10%; the anticipated opportunity is likely to be distributed across various steps involved in antibody discovery, antibody discovery method, nature of antibody generated and geographies.
The market for antibody discovery platforms is currently being driven by the revenues from the licensing deals; it is anticipated to reach USD 5.9 billion by 2030.